Cancer risk in people infected with human immunodeficiency virus in the United States.
about
Network-based analysis of comorbidities risk during an infection: SARS and HIV case studiesInterventions for previously untreated patients with AIDS-associated Non-Hodgkin´s LymphomaEpidemiology of lung cancerChallenges in treating malignancies in HIV in NigeriaThe role of HPV in head and neck cancer and review of the HPV vaccineCo-infections and Pathogenesis of KSHV-Associated MalignanciesNon-AIDS definings malignancies among human immunodeficiency virus-positive subjects: Epidemiology and outcome after two decades of HAART eraOral human papillomavirus infection and head and neck cancers in HIV-infected individualsLiver transplantation: immunosuppression and oncologyThe rising challenge of non-AIDS-defining cancers in HIV-infected patientsInfection and cancer in multicellular organismsThe evolving scenario of non-AIDS-defining cancers: challenges and opportunities of careEpidemic of lung cancer in patients with HIV infectionHIV infection, aging, and immune function: implications for cancer risk and preventionHuman papilloma virus in head and neck cancers-role and relevance in clinical managementHematopoietic cell transplantation for B-cell lymphoma: an updateCancer stage at diagnosis in patients infected with the human immunodeficiency virus and transplant recipients.Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes ProjectUpregulation of xCT by KSHV-encoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxidative stressDeveloping clinical strength-of-evidence approach to define HIV-associated malignancies for cancer registration in KenyaLarge scale analysis of phenotype-pathway relationships based on GWAS resultsAnal cancer and intraepithelial neoplasia: epidemiology, screening and prevention of a sexually transmitted diseaseMapping the Epidemiology of Kaposi Sarcoma and Non-Hodgkin Lymphoma Among Children in Sub-Saharan Africa: A Review.Induction of hyaluronan production by oncogenic KSHV and the contribution to viral pathogenesis in AIDS patients.Thoracic diseases associated with HIV infection in the era of antiretroviral therapy: clinical and imaging findings.Risk Of Colorectal Cancer And Associated Mortality In Hiv: A Systematic Review And Meta-Analysis.Lung cancer in HIV patients and their parents: a Danish cohort study.Importance of microbial natural products and the need to revitalize their discovery.Human papillomavirus-related disease in people with HIVA Phase Ib Study of Sorafenib (BAY 43-9006) in Patients with Kaposi Sarcoma.The challenge of AIDS-related malignancies in sub-Saharan Africa.Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Consortium clinical trials 010 and 034Oral human papillomavirus detection in older adults who have human immunodeficiency virus infection.Pivotal advance: Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10 secretion by macrophages and monocytes.Long-term nitrite inhalant exposure and cancer risk in MSM.Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study.The complexity of HIV persistence and pathogenesis in the lung under antiretroviral therapy: challenges beyond AIDS.Progress and pitfalls in defining the influence of highly active antiretroviral therapy on human papillomavirus-associated cervical diseaseRole of human papillomavirus in oropharyngeal squamous cell carcinoma: A review.Diabetes insipidus and hypopituitarism in HIV: an unexpected cause.
P2860
Q21284301-18ED6236-278F-4571-A360-BC160254E5B8Q24240190-1450C96F-FC5B-435E-B470-B449FCD6573BQ24600475-4B90630D-74EB-48DD-9FAE-3A028CF753EBQ24628763-92952F2F-71F3-4E28-8790-175775659430Q24630128-314B0EEF-2B00-4DBB-BCB2-A89F2991607EQ26766493-B03FCD98-B987-40AC-B110-88BD7542AEE7Q26797897-9128A11D-97BD-44F7-9CB3-5275F7E6A370Q26825257-005AAE2B-A46F-4B81-8554-E2DF1AE6AFB3Q26827252-8B48C69D-5932-46AA-8AA0-784FE0C4CF00Q26861496-D6011F76-5A04-4218-A124-2D795E48E384Q26863592-D7BE5EF6-F1FE-495F-8D0A-786FD6ADC01DQ26991549-36E35DB2-8AEB-4E73-BD26-77FFBFF8E35CQ27000028-C1EBB523-203A-4814-B250-385F1C83C48FQ27004165-039AB425-DF95-4353-ABD8-EA2703CCDF64Q27021230-C954AA9C-8B2F-4C60-B98F-FF836790B23BQ27026617-64AA4DA7-3C7E-41CB-AE8E-A3083FF9ABDAQ27335991-0CDD6013-4B54-4ACA-B37C-09273031E816Q28393769-C724C806-D02F-4E77-849F-DC6742348ABFQ28472699-870C3939-CC85-4EE5-A95F-E9ECCED6FA26Q28539066-AFDAE227-51C2-43D5-8AA1-6B5B147273FBQ28540586-3A358199-E5F8-4617-A7B1-F282C900DB8DQ28650872-1BE53CA9-778B-43FA-99C3-05EC5B9AF573Q30251585-E59784AF-CF0F-4B44-B453-FF5FB7B6179EQ30357883-AE1DC5B8-FF29-415C-B562-55BEBCBF78B9Q30364647-2A35C077-CF6F-4886-80B5-B62C27E3B918Q30491585-CE007E85-3511-4EBF-8755-B8FE2FA78BABQ31021219-7B2EE209-9929-44D0-A938-4711E0C8C05AQ31128037-EFC7FEE7-FC06-451A-818C-152D28C00F00Q33425662-4BE22EE1-B91D-445C-94AC-DC562BC94CC3Q33440392-1B54DB44-A0F4-424C-AAA9-3C7CE82E9F0EQ33523293-B8069F66-C2EF-43A9-AA77-0CF6FCFBFE63Q33561185-BB0DEA9F-BCD2-43B2-B56B-272C5B1C979BQ33570603-1F627FC4-8655-4B4B-8AEF-40E47EF07314Q33571183-9740F080-EE58-481C-AB31-C26414E3B330Q33631041-9ED9D6E4-F664-4A69-BCAA-F7F9731C31F5Q33651611-6727EEA3-53F2-417B-AE36-5D0A02227828Q33705883-2825F0A0-8872-4232-8A1D-2D4A1C00DC00Q33769717-05986979-8DB1-444F-9A61-6084486D32F9Q33770030-B7EEAF45-E7AE-49E2-B5EE-527B50CA6A61Q33787740-536079CE-B94C-4E16-8152-1CDEFB031A72
P2860
Cancer risk in people infected with human immunodeficiency virus in the United States.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Cancer risk in people infected with human immunodeficiency virus in the United States.
@en
Cancer risk in people infected with human immunodeficiency virus in the United States.
@nl
type
label
Cancer risk in people infected with human immunodeficiency virus in the United States.
@en
Cancer risk in people infected with human immunodeficiency virus in the United States.
@nl
prefLabel
Cancer risk in people infected with human immunodeficiency virus in the United States.
@en
Cancer risk in people infected with human immunodeficiency virus in the United States.
@nl
P2093
P356
P1476
Cancer risk in people infected with human immunodeficiency virus in the United States.
@en
P2093
Allison Crutchfield
Eric A Engels
H Irene Hall
Helene Cross
Jack L Finch
James J Goedert
Karen S Pawlish
Rebecca Grigg
Robert J Biggar
Tara Hylton
P304
P356
10.1002/IJC.23487
P577
2008-07-01T00:00:00Z